Phantom Cine Toolkit Keygens

Phantom Cine Toolkit for Final Cut Studio lets users open and play Vision Research's Phantom Cine movie files. Vision Research creates and manufactures high speed digital cameras that can capture imagery at several thousand frames a second. Their cameras have been used in many industries, including Science, Manufacturing, Aerospace, Defense, as well as Film and Television. This package lets the user open the raw Phantom Cine movies and choose from different debayer algorithms, color correction matrices, as well as white balance and gamma modes. A SMPTE Timecode track is created as well, from the Timestamps inside the Phantom Cine file. As with any QuickTime component, the Operating system is fully aware of the new file format, allowing for Finder Thumbnails, and Spotlight integration. Price USD499 License Free to try File Size 2.21 MB Version 4.0.2929 Operating System Mac OS X 10.9 Macintosh Mac OS X 10.7 Mac OS X 10.8 System Requirements QuickTime 7.6.6 or later.

By registering you become a member of the CBS Interactive family of sites and you have read and agree to the, and. You agree to receive updates, alerts and promotions from CBS and that CBS may share information about you with our marketing partners so that they may contact you by email or otherwise about their products or services.

Phantom Cine Toolkit for Final Cut Studio lets users open and play Vision Research's Phantom Cine movie files. Vision Research creates and m. Get access to over 300 TB of Movies, Games, Applications and MP3s. Download the UseNeXT-Client - high-speed downloading (16mbit) and 100% anonymous! FULL Download Phantom Cine Toolkit for Final Cut Studio v2.5.2251 MacOSX at PromoDDL.com.

You will also receive a complimentary subscription to the ZDNet's Tech Update Today and ZDNet Announcement newsletters. You may unsubscribe from these newsletters at any time. ACCEPT & CLOSE.

Enumerated Values: YES NO If this Attribute is absent, then the subject may or may not be a phantom. This attribute describes a characteristic of the Imaging Subject. It is distinct from Quality Control Image (0028,0300) in the General Image Module, which is used to describe an image acquired. Referenced Patient Sequence (0008,1120) 3 A sequence that provides reference to a Patient SOP Class/Instance pair. Only a single Item is permitted in this Sequence.

>Include Patient's Birth Time (0010,0032) 3 Birth time of the Patient. Other Patient IDs (0010,1000) 3 Other identification numbers or codes used to identify the patient. Other Patient IDs Sequence (0010,1002) 3 A sequence of identification numbers or codes used to identify the patient, which may or may not be human readable, and may or may not have been obtained from an implanted or attached device such as an RFID or barcode.

One or more Items are permitted in this sequence. >Patient ID (0010,0020) 1 An identification number or code used to identify the patient. >Include >Type of Patient ID (0010,0022) 1 The type of identifier in this item. Note The identifier is coded as a string regardless of the type, not as a binary value. Other Patient Names (0010,1001) 3 Other names used to identify the patient. Ethnic Group (0010,2160) 3 Ethnic group or race of the patient. Patient Comments (0010,4000) 3 User-defined additional information about the patient.

Patient Species Description (0010,2201) 1C The species of the patient. Required if the patient is an animal and if Patient Species Code Sequence (0010,2202) is not present. May be present otherwise.

Patient Species Code Sequence (0010,2202) 1C The species of the patient. Only a single Item shall be included in this sequence. Required if the patient is an animal and if Patient Species Description (0010,2201) is not present.

May be present otherwise. >Include Defined.

Patient Breed Description (0010,2292) 2C The breed of the patient. Required if the patient is an animal and if Patient Breed Code Sequence (0010,2293) is empty. May be present otherwise. Patient Breed Code Sequence (0010,2293) 2C The breed of the patient. Zero or more Items shall be included in this sequence. Required if the patient is an animal.

>Include Defined. Breed Registration Sequence (0010,2294) 2C Information identifying an animal within a breed registry. Zero or more Items shall be included in this sequence. Required if the patient is an animal.

>Breed Registration Number (0010,2295) 1 Identification number of an animal within the registry. >Breed Registry Code Sequence (0010,2296) 1 Identification of the organization with which an animal is registered. Only a single Item shall be included in this sequence. >>Include Defined.

Responsible Person (0010,2297) 2C Name of person with medical decision making authority for the patient. Required if the patient is an animal.

May be present otherwise. Responsible Person Role (0010,2298) 1C Relationship of Responsible Person to the patient. See for Defined Terms. Required if Responsible Person is present and has a value. Responsible Organization (0010,2299) 2C Name of organization with medical decision making authority for the patient. Required if patient is an animal. May be present otherwise.

Patient Identity Removed (0012,0062) 3 The true identity of the patient has been removed from the Attributes and the Pixel Data. • This may be used to describe the extent or thoroughness of the de-identification, for example whether or not the de-identification is for a 'Limited Data Set' (as per HIPAA Privacy Rule). • The characteristics of the de-identifying equipment and/or the responsible operator of that equipment may be recorded as an additional item of the Contributing Equipment Sequence (0018,A001) in the SOP Common Module. De-identifying equipment may use a Purpose of Reference of (109104,DCM,'De-identifying Equipment').

Required if Patient Identity Removed (0012,0062) is present and has a value of YES and De-identification Method Code Sequence (0012,0064) is not present. May be present otherwise. De-identification Method Code Sequence (0012,0064) 1C A code describing the mechanism or method use to remove the patient's identity. One or more Items shall be included in this sequence. Multiple items are used if successive de-identification steps have been performed or to describe options of a defined profile. Required if Patient Identity Removed (0012,0062) is present and has a value of YES and De-identification Method (0012,0063) is not present. May be present otherwise.

>Include Defined. • described in plain text in Patient Breed Description (0010,2292), e.g., 'Border Collie American Bulldog mix', or just 'Mixed', or • coded as multiple specific breeds by composing the mix as multiple items of Patient Breed Code Sequence (0010,2293), e.g., (L-809A2,SRT,'Border Collie dog breed') followed by (L-80974,SRT, 'American Bulldog breed'), or • encoded non-specifically with a code that means 'mixed breed' of the appropriate species, as defined in, which is included in, e.g., (L-809DF,SRT,'Mixed breed dog'). Attribute Name Tag Type Attribute Description Clinical Trial Sponsor Name (0012,0010) 1 The name of the clinical trial sponsor.

Clinical Trial Protocol ID (0012,0020) 1 Identifier for the noted protocol. Clinical Trial Protocol Name (0012,0021) 2 The name of the clinical trial protocol.

Clinical Trial Site ID (0012,0030) 2 The identifier of the site responsible for submitting clinical trial data. Clinical Trial Site Name (0012,0031) 2 Name of the site responsible for submitting clinical trial data. See Clinical Trial Subject ID (0012,0040) 1C The assigned identifier for the clinical trial subject.

Shall be present if Clinical Trial Subject Reading ID (0012,0042) is absent. May be present otherwise. Clinical Trial Subject Reading ID (0012,0042) 1C Identifies the subject for blinded evaluations.

Shall be present if Clinical Trial Subject ID (0012,0040) is absent. May be present otherwise. Clinical Trial Protocol Ethics Committee Name (0012,0081) 1C Name of the Ethics Committee or Institutional Review Board (IRB) responsible for approval of the Clinical Trial. Required if Clinical Trial Protocol Ethics Committee Approval Number (0012,0082) is present. Clinical Trial Protocol Ethics Committee Approval Number (0012,0082) 3 Approval number issued by committee described in Clinical Trial Protocol Ethics Committee Name (0012,0081). • Clinical Trial Sponsor Name (0012,0010), • Clinical Trial Protocol ID (0012,0020), • Clinical Trial Subject ID (0012,0040) (or Clinical Trial Subject Reading ID (0012,0042) for blinded evaluations), and • Clinical Trial Site ID (0012,0030).

For trials in which subject identifiers are unique within the scope of the Clinical Trial Protocol (e.g., if subject identifiers are centrally assigned or contain the site identifier) the Clinical Trial Site ID (0012,0030) is not required to identify subjects. Attribute Name Tag Type Attribute Description Study Instance UID (0020,000D) 1 Unique identifier for the Study. Study Date (0008,0020) 2 Date the Study started. Study Time (0008,0030) 2 Time the Study started. Referring Physician's Name (0008,0090) 2 Name of the patient's referring physician Referring Physician Identification Sequence (0008,0096) 3 Identification of the patient's referring physician. Only a single item is permitted in this sequence. >Include Study ID (0020,0010) 2 User or equipment generated Study identifier.

Accession Number (0008,0050) 2 A RIS generated number that identifies the order for the Study. Issuer of Accession Number Sequence (0008,0051) 3 Identifier of the Assigning Authority that issued the Accession Number. Only a single Item is permitted in this sequence. >Include Study Description (0008,1030) 3 Institution-generated description or classification of the Study (component) performed.

Physician(s) of Record (0008,1048) 3 Names of the physician(s) who are responsible for overall patient care at time of Study (see for Performing Physician) Physician(s) of Record Identification Sequence (0008,1049) 3 Identification of the physician(s) who are responsible for overall patient care at time of Study. One or more items are permitted in this sequence. If more than one Item, the number and order shall correspond to the value of Physician(s) of Record (0008,1048), if present.

>Include Name of Physician(s) Reading Study (0008,1060) 3 Names of the physician(s) reading the Study. Physician(s) Reading Study Identification Sequence (0008,1062) 3 Identification of the physician(s) reading the Study. One or more items are permitted in this sequence. If more than one Item, the number and order shall correspond to the value of Name of Physician(s) Reading Study (0008,1060), if present. >Include Requesting Service Code Sequence (0032,1034) 3 Institutional department where the request initiated.

Only a single item is permitted in this sequence. >Include Defined. Referenced Study Sequence (0008,1110) 3 A sequence that provides reference to a Study SOP Class/Instance pair. One or more Items are permitted in this Sequence. >Include Procedure Code Sequence (0008,1032) 3 A Sequence that conveys the type of procedure performed.

One or more Items are permitted in this Sequence. >Include No Baseline CID is defined. Reason For Performed Procedure Code Sequence (0040,1012) 3 Coded reason(s) for performing this procedure. Attribute Name Tag Type Attribute Description Admitting Diagnoses Description (0008,1080) 3 Description of the admitting diagnosis (diagnoses) Admitting Diagnoses Code Sequence (0008,1084) 3 A sequence that conveys the admitting diagnosis (diagnoses).

One or more Items are permitted in this Sequence. >Include No Baseline CID is defined.

Patient's Age (0010,1010) 3 Age of the Patient. Patient's Size (0010,1020) 3 Length or size of the Patient, in meters. Patient's Weight (0010,1030) 3 Weight of the Patient, in kilograms. Patient's Size Code Sequence (0010,1021) 3 Patient's size category code One or more Items are permitted in this sequence. >Include Baseline CID is for pediatric patients Baseline CID is for CT calcium scoring Occupation (0010,2180) 3 Occupation of the Patient. Additional Patient History (0010,21B0) 3 Additional information about the Patient's medical history.

Admission ID (0038,0010) 3 Identifier of the visit as assigned by the healthcare provider Issuer of Admission ID Sequence (0038,0014) 3 Identifier of the Assigning Authority that issued Admission ID (0038,0010). Only a single Item is permitted in this sequence. >Include Service Episode ID (0038,0060) 3 Identifier of the Service Episode as assigned by the healthcare provider Issuer of Service Episode ID Sequence (0038,0064) 3 Identifier of the Assigning Authority that issued the Service Episode ID (0038,0060). Only a single Item is permitted in this sequence. >Include Service Episode Description (0038,0062) 3 Description of the type of service episode. Patient's Sex Neutered (0010,2203) 2C Whether or not a procedure has been performed in an effort to render the patient sterile.

Attribute Name Tag Type Attribute Description Clinical Trial Time Point ID (0012,0050) 2 An identifier specifying the one or more studies that are grouped together as a clinical time point or submission in a clinical trial. Clinical Trial Time Point Description (0012,0051) 3 A description of a set of one or more studies that are grouped together to represent a clinical time point or submission in a clinical trial. Consent for Clinical Trial Use Sequence (0012,0083) 3 A Sequence that conveys information about consent for Clinical Trial use of the composite instances within this Study. One or more Items are permitted in this sequence. >Distribution Type (0012,0084) 1C The type of distribution for which consent to distribute has been granted. Defined Terms: NAMED_PROTOCOL RESTRICTED_REUSE PUBLIC_RELEASE See. Required if Consent for Distribution Flag (0012,0085) equals YES or WITHDRAWN.

>Clinical Trial Protocol ID (0012,0020) 1C The identifier of the protocol for which consent to distribute has been granted. Required if Distribution Type (0012,0084) is NAMED_PROTOCOL and the protocol is not that which is specified in Clinical Trial Protocol ID (0012,0020) in the Clinical Trial Subject Module. >Consent for Distribution Flag (0012,0085) 1 Whether or not consent to distribute has been granted for the purpose described in Distribution Type (0012,0084). C.7.2.3. Bluetooth Serial Connection Matlab Central. 1.2 Consent For Clinical Trial Use Sequence For applications such as clinical trials, the distribution of composite instances in Studies, whether containing identifying information or partially or completely de-identified, may need to be controlled. Permission for distribution is usually granted under the control of the patient (through informed consent), the ethics committee or institutional review board responsible for the study, and the sponsor of the study through contractual means. The Consent for Clinical Trial Use Sequence (0012,0083) is intended to encode the result of the consent process to allow appropriate subsequent handling of the instances.

The Defined Terms for Distribution Type (0012,0084) mean that consent has been issued to distribute for the following purposes. • There is no intent to convey in this sequence further details of the often complex consent and approval process. Download Adobe Flash Player For Blackberry Smartphone. Further information about the protocol and ethics committee may be found in the Clinical Trials modules, if present.

• There is no identification of an individual responsible for the approval or granting consent, since in the case of a clinical trial subject granting informed consent, the presence of this information would breach de-identification requirements. • Multiple sequence items may be present; for example a Study may be approved for distribution for conducting multiple explicitly named protocols.

• Whether or not the instances have been adequately de-identified for any particular purpose of distribution is not defined by the Attributes in the Consent for Clinical Trial Use Sequence (0012,0083). Other Attributes address this, such as Patient Identity Removed (0012,0062), De-identification Method (0012,0063), De-identification Method Code Sequence (0012,0064) and Burned In Annotation (0028,0301). • It is possible that the list of Defined Terms for Distribution Type (0012,0084) may be extended in future for other purposes, not necessarily related to the conduct of clinical trials.